Secondarily estimated cure fraction and five-year recurrence-free conditional survival probabilities among patients undergoing surgical resection for hepatocellular carcinoma presenting with minor gross vascular invasion

[1]  Dan Li,et al.  A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resection , 2021, World Journal of Surgical Oncology.

[2]  Junyu Huo,et al.  Identification and validation of a five-gene prognostic signature for hepatocellular carcinoma , 2021, World Journal of Surgical Oncology.

[3]  Jiwei Huang,et al.  Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis , 2021, World Journal of Surgical Oncology.

[4]  Chi Zhang,et al.  A prognostic model for hepatocellular carcinoma based on apoptosis-related genes , 2021, World Journal of Surgical Oncology.

[5]  W. Peng,et al.  The impact of thrombocytopenia on prognosis of HBV-related small hepatocellular carcinoma: a propensity score matching analysis , 2021, World Journal of Surgical Oncology.

[6]  Y. Chong,et al.  Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma , 2020, World Journal of Surgical Oncology.

[7]  T. Aoki,et al.  Is left-sided involvement of hepatocellular carcinoma an important preoperative predictive factor of poor outcome? , 2020, World Journal of Surgical Oncology.

[8]  Guangtao Sun,et al.  Human nuclear receptors (NRs) genes have prognostic significance in hepatocellular carcinoma patients , 2020, World Journal of Surgical Oncology.

[9]  T. Jiang,et al.  Irreversible electroporation in patients with liver tumours: treated-area patterns with contrast-enhanced ultrasound , 2020, World Journal of Surgical Oncology.

[10]  Wei Wei,et al.  Resection vs. Sorafenib for Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Real World, Propensity Score Matched Analytic Study , 2020, Frontiers in Oncology.

[11]  Zun-yi Zhang,et al.  Resection might be a meaningful choice for hepatocellular carcinoma with portal vein thrombosis , 2019, Medicine.

[12]  V. Mazzaferro,et al.  The chances of hepatic resection curing hepatocellular carcinoma. , 2019, Journal of hepatology.

[13]  J. Sicklick,et al.  Guidelines Insights: Hepatobiliary Cancers, Version 2.2019. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[14]  L. Huo,et al.  Short-term and long-term outcomes of liver resection for HCC patients with portal vein tumor thrombus , 2019, Cell & Bioscience.

[15]  H. El‐Serag,et al.  Epidemiology and Management of Hepatocellular Carcinoma. , 2019, Gastroenterology.

[16]  H. Wang,et al.  Prognostic significance of microvascular invasion in tumor stage for hepatocellular carcinoma , 2017, World Journal of Surgical Oncology.

[17]  J. Bruix,et al.  Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies. , 2017, Journal of hepatology.

[18]  K. Yamashita,et al.  Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification , 2017, World Journal of Surgical Oncology.

[19]  J. Sicklick,et al.  NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[20]  M. Kudo,et al.  Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. , 2016, Journal of hepatology.

[21]  Martin Schumacher,et al.  Conditional Survival: A Useful Concept to Provide Information on How Prognosis Evolves over Time , 2015, Clinical Cancer Research.

[22]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[23]  C. Sakakura,et al.  Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis. , 2015, World journal of gastroenterology.

[24]  Chia-Yang Hsu,et al.  Vascular Invasion in Hepatocellular Carcinoma: Prevalence, Determinants and Prognostic Impact , 2014, Journal of clinical gastroenterology.

[25]  T. Showalter,et al.  Conditional Survival Probabilities for Patients With Resected Pancreatic Adenocarcinoma , 2014, American journal of clinical oncology.

[26]  Katherine S Panageas,et al.  Dynamic prognostication using conditional survival estimates , 2013, Cancer.

[27]  J. Skibber,et al.  An Individualized Conditional Survival Calculator for Patients with Rectal Cancer , 2013, Diseases of the colon and rectum.

[28]  Bart Barlogie,et al.  Cure Models as a Useful Statistical Tool for Analyzing Survival , 2012, Clinical Cancer Research.

[29]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[30]  L. Roberts,et al.  Epidemiology and management of hepatocellular carcinoma. , 2010, Infectious disease clinics of North America.

[31]  W. Lau,et al.  Surgical Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus , 2010, Annals of Surgical Oncology.

[32]  Peter C. Austin,et al.  Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research , 2009, Commun. Stat. Simul. Comput..

[33]  Paul W Dickman,et al.  Estimating and modeling the cure fraction in population-based cancer survival analysis. , 2007, Biostatistics.

[34]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[35]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[36]  [Practice guidelines for management of hepatocellular carcinoma 2009]. , 2009, The Korean journal of hepatology.

[37]  Wei-Mou Zheng,et al.  T E C H N I C a L a D V a N C E Open Access , 2022 .